Maiden Pharmaceuticals of India, whose cough syrups have been connected to the deaths of children in Gambia, denied tampering with test samples or bribing officials to do so on Saturday, as alleged in a complaint under investigation by local health officials.
India is close to finishing an investigation into a “comprehensive and exhaustive” complaint that a state drug regulator, in return for a bribe, helped switch samples of cough syrups linked to the deaths of children in Gambia before the samples were tested in India, the investigator told Reuters.
British resident Alan Boardman is launching a campaign to supply underprivileged families in the Gambia with eyeglasses. Alan Boardman, who has
Earlier this year, Micron announced successful clinical data from a phase I/II study in the Gambia, which evaluated the safety, immunogenicity, and acceptability of the leading commercially available MR vaccine delivered by Micron’s microarray technology in adults, toddlers and infants as young as nine months old.
Pregnant women, including some Gambians, have been involved in clinical trials for Pfizer’s maternal respiratory syncytial virus (RSV) vaccine since 2019. Nevertheless, a study conducted by the British weekly peer-reviewed medical journal BMJ has shown that many of the trial participants were not informed by Pfizer about the nature of the vaccine they were vaccinated against, and that the trial of a comparable GSK vaccine was halted due to safety concerns regarding preterm birth.
The Albera Salut Foundation of Peralada together with another NGO “With Your Hands”, recently donated an electrocardiogram machine to the Farafenni
The Government of The Gambia has officially filed an indictment against three senior officials from the Ministry of Health and Health
Never miss any important news. Subscribe to our newsletter.
Never miss any important news. Subscribe to our newsletter.
